Home › Mielofibrosi › North Carolina › Durham
Studi clinici su Mielofibrosi a Durham, NC
12 studi su Mielofibrosi cercano partecipanti presso sedi a Durham e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
In reclutamentoFase 1/2
- Duke Cancer Institute, Durham
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
In reclutamentoFase 3
- Duke Blood Cancer Center, Durham
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
In reclutamentoFase 1
- University of North Carolina At Chapel Hill, Chapel Hill · a 10 mi di distanza
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
In reclutamentoFase 1
- Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · a 10 mi di distanza
Registry of Older Patients With Cancer
In reclutamentoStudio osservazionale
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi di distanza
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
In reclutamentoFase 1
- University of North Carolina, Chapel Hill · a 10 mi di distanza
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
In reclutamentoFase 3
- DUHS Duke Blood Cancer Center ( Site 6005), Durham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
In reclutamentoFase 2
- University of North Carolina, Chapel Hill · a 10 mi di distanza
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
In reclutamentoFase 2
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Chapel Hill · a 10 mi di distanza
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
In reclutamentoStudio osservazionale
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi di distanza
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
In reclutamentoFase 3
- Duke University Medical Center, Durham
Studi su Mielofibrosi in altre città
- Houston, TX19 studi
- New York City, NY18 studi
- Boston, MA12 studi
- Columbus, OH11 studi
- Seattle, WA11 studi
- Salt Lake City, UT10 studi
- Miami, FL10 studi
- Nashville, TN9 studi
- Cleveland, OH9 studi
- Tampa, FL9 studi
- Atlanta, GA9 studi
- Baldwin Park, CA9 studi
Altri studi a Durham
- Cancro al seno63 studi
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule39 studi
- Mieloma multiplo37 studi
- Cancro metastatico33 studi
- Leucemia mieloide acuta33 studi
- Cancro ai polmoni32 studi
- Cancro alla prostata32 studi
- Cancro colorettale28 studi
- Leucemia linfatica cronica27 studi
- Cancro ovarico27 studi
- Insufficienza cardiaca26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.